ChartRow logo
DOCS
$33.35+6.04%
as of close, Oct 20, 2026
☾ AH $33.35 +6.04%
Share this page

DOCS financial statements

The full income statement, balance sheet, and cash-flow statement for Doximity Inc. (DOCS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 185.7M2024-09 186.8M2024-12 187.6M2025-03 188.9M2025-06 187.5M2025-09 188.1M2025-12 185.0M2026-03 183.1M2026-06 178.2M-4.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Revenue645M+13.1%570M+20.0%475M+13.5%419M+22.0%344M+66.0%
575M+11.7%515M+21.1%425M+16.2%366M+20.3%304M+72.9%
Cost of revenue70.3M+25.9%55.9M+10.3%50.7M-5.3%53.5M+34.4%39.8M+27.5%
360M+25.4%287M+9.9%261M+8.5%240M+26.4%190M+55.4%
Research & development131M+40.5%93.0M+13.5%82.0M+2.2%80.2M+28.6%62.4M+42.1%
Selling, general & administrative65.3M+42.9%45.7M+20.7%37.8M+2.9%36.7M+2.8%35.7M+116.7%
General & administrative65.3M+42.9%45.7M+20.7%37.8M+2.9%36.7M+2.8%35.7M+116.7%
Selling & marketing164M+12.3%146M+9.5%133M+7.8%124M+34.1%92.1M+48.5%
Restructuring—2.30M-71.0%7.94M0.000.00
Amortization of intangibles6.50M+51.2%4.30M-6.5%4.60M-4.2%4.80M+380.0%1.00M-9.1%
Operating income215M-5.7%228M+39.0%164M+31.0%125M+10.2%114M+113.0%
Other non-operating income-806K-226.3%-247K-498.4%62.0K+142.5%-146K+67.4%-448K-110.0%
Pre-tax income250M-5.1%264M+42.3%185M+39.1%133M+16.8%114M+97.3%
Income tax54.0M+33.6%40.4M+7.4%37.6M+85.0%20.3M+149.9%-40.8M-639.5%
196M-12.2%223M+51.2%148M+30.8%113M-27.1%155M+208.3%
Net income to common——148M+30.8%113M-15.3%133M+518.2%
$0.98-11.7%$1.11+54.2%$0.72+35.8%$0.53-24.3%$0.70+204.3%
EPS (basic)$1.05-11.8%$1.19+52.6%$0.78+34.5%$0.58-29.3%$0.82+182.8%
Weighted-avg shares (basic)187M+0.1%187M-1.8%190M-1.6%193M+18.2%163M+119.9%
Weighted-avg shares (diluted)199M-1.1%201M-2.2%206M-3.6%213M+11.7%191M+100.8%
Balance Sheetas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
944M-13.3%1.09B+19.2%913M-6.4%975M+7.9%904M+331.8%
Cash & equivalents219M+4.6%210M+116.6%96.8M-38.8%158M+40.1%113M+69.9%
Cash & short-term investments———809M+14.3%708M
Accounts receivable145M+12.8%128M+26.7%101M-5.3%107M+32.0%81.1M+61.1%
Prepaid expenses50.9M+14.1%44.6M-8.4%48.7M+77.7%27.4M+41.0%19.4M+81.8%
1.12B-11.1%1.26B+17.1%1.08B-5.1%1.14B+14.7%991M+293.8%
Property, plant & equipment18.1M+32.4%13.7M+10.9%12.3M+9.2%11.3M+32.9%8.49M+11.7%
Operating lease right-of-use7.14M-19.6%8.89M-27.9%12.3M-10.8%13.8M+1171.3%1.09M-18.8%
Goodwill85.0M+25.1%67.9M+0.0%67.9M+0.0%67.9M+259.2%18.9M+0.0%
Intangible assets35.3M+53.1%23.1M-15.5%27.3M-14.2%31.8M+302.5%7.91M-17.6%
Deferred tax assets32.0M-46.7%60.0M+33.2%45.1M+29.1%34.9M-28.1%48.6M+2199.1%
Other non-current assets1.92M-9.4%2.12M+45.5%1.46M-11.9%1.65M-26.9%2.26M-17.9%
155M-0.8%156M+6.1%147M+5.6%140M+25.4%111M+9.1%
Accounts payable4.01M+195.6%1.36M-39.8%2.25M+77.1%1.27M+174.7%463K-69.4%
Accrued liabilities42.8M+11.5%38.4M-12.1%43.7M+39.9%31.2M+23.6%25.3M+55.2%
Deferred revenue106M-7.2%114M+15.3%99.1M-5.8%105M+23.9%84.9M+2.0%
Current lease liability2.11M-4.6%2.21M+2.9%2.15M+22.7%1.75M+172.9%642K-33.8%
173M-4.9%182M+2.1%178M+4.2%171M+51.4%113M+8.9%
Deferred revenue (non-current)400K+42.9%280K+32.7%211K+6.6%198K+153.8%78.0K-64.5%
Non-current lease liability8.07M-20.7%10.2M-17.8%12.4M-10.7%13.9M+3006.3%447K+57.4%
Operating lease liability (total)10.2M-17.8%12.4M-14.8%14.5M-7.0%15.6M+1335.9%1.09M
Other non-current liabilities9.40M+0.2%9.38M+29.9%7.22M+482.6%1.24M+29.7%956K-1.6%
951M-12.2%1.08B+20.1%901M-6.7%966M+10.0%879M+1216.4%
Preferred stock0.000.000.000.000.00
Common stock183K-3.2%189K+1.1%187K-3.6%194K+1.0%192K+131.3%
Additional paid-in capital1.00B+12.0%894M+8.5%824M+8.1%762M+8.5%703M+2214.4%
Retained earnings-51.1M-127.3%187M+133.6%80.0M-63.3%218M+14.0%191M+426.1%
Accumulated other comprehensive income28.0K-97.9%1.32M+149.7%-2.66M+81.1%-14.1M+7.9%-15.3M-72728.6%
Total liabilities & equity1.12B-11.1%1.26B+17.1%1.08B-5.1%1.14B+14.7%991M+293.8%
Common shares issued183M-3.1%189M+1.2%187M-3.8%194M+0.8%192M+132.1%
Common shares outstanding183M-3.1%189M+1.2%187M-3.8%194M+0.8%192M+132.1%
Cash Flowas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
326M+19.5%273M+48.4%184M+2.5%180M+41.9%127M+52.5%
Depreciation & amortization14.4M+34.9%10.7M+3.8%10.3M-0.2%10.3M+104.0%5.04M+36.1%
Intangible amortization6.50M+51.2%4.30M-6.5%4.60M-4.2%4.80M+380.0%1.00M-9.1%
Share-based compensation122M+68.0%72.4M+41.7%51.1M+6.8%47.8M+52.1%31.4M+333.6%
Deferred income taxes32.1M+377.2%-11.6M-34.9%-8.59M-165.0%13.2M+132.1%-41.2M-927.1%
Change in receivables16.9M-38.0%27.2M+781.3%-3.99M-115.2%26.2M-15.4%31.0M+51.7%
147M+602.3%-29.3M-193.9%31.2M+152.0%-59.9M+90.6%-641M-809.7%
Capital expenditure0.000.00-100.0%147K-91.4%1.70M-11.0%1.91M+680.4%
Free cash flow326M+19.5%273M+48.6%184M+3.4%178M+42.7%125M+50.7%
Acquisitions26.5M0.000.00-100.0%53.5M0.00-100.0%
Sales/maturities of investments561M-11.6%635M+46.0%435M+423.4%83.1M+73.5%47.9M+18.2%
Other investing activities——0.000.00+100.0%-595K-5058.3%
-464M-253.9%-131M+52.6%-277M-271.4%-74.5M-113.3%560M+10264.6%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased432M+258.8%120M-57.1%281M+229.0%85.3M+3062.5%2.70M+33.4%
Dividends paid0.000.000.000.000.00
Net change in cash9.56M-91.5%113M+284.2%-61.2M-235.4%45.2M-2.6%46.4M+158.4%
Income taxes paid21.8M-60.8%55.7M+8.5%51.3M+880.2%5.23M+2439.3%206K-96.6%
Valuation Ratiosas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Market cap4.27B-61.1%11.0B+118.8%5.01B-20.2%6.28B-37.3%10.0B
P/E21.8×-55.7%49.1×+34.9%36.4×-34.6%55.7×-14.0%64.7×
P/S6.6×-65.6%19.2×+79.6%10.7×-28.6%15.0×-48.6%29.2×
P/B4.5×-55.7%10.1×+74.7%5.8×-10.9%6.5×-43.0%11.4×
P/FCF13.1×-67.4%40.1×+33.4%30.1×-14.8%35.3×-56.1%80.4×
Earnings yield4.6%+125.7%2.0%-25.9%2.7%+52.9%1.8%+16.3%1.5%
FCF yield7.7%+207.0%2.5%-25.0%3.3%+17.4%2.8%+127.7%1.2%
Source filing10-K10-K10-K10-K10-K

About this data

Source: DOCS’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all DOCS filings on SEC EDGAR → Not investment advice.